The objective of the Autism Biomarkers Consortium for Clinical Trials (ABC-CT) is to evaluate a set of lab-based behavioral video tracking (VT), electroencephalography (EEG), and eye tracking (ET) measures for use in clinical trials with children with autism spectrum disorder (ASD). Within the larger organizational structure of the ABC-CT, the Data Acquisition and Analytic Core (DAAC) oversees the standardization of VT, EEG, and ET data acquisition, data processing, and data analysis.
This includes designing and documenting data acquisition and analytic protocols and manuals; facilitating site training in acquisition; data acquisition quality control (QC); derivation and validation of dependent variables (DVs); and analytic deliverables including preparation of data for submission to the National Database for Autism Research (NDAR).
.
SAA-PEG-SAA |
|||
abx085047-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 543.6 |
SAA-PEG-SAA |
|||
abx085047-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 543.6 |
SAA-PEG-SAA,1K |
|||
33-HO015015-1K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,2K |
|||
33-HO015015-2K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,3.4K |
|||
33-HO015015-3.4K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,5K |
|||
33-HO015015-5K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,10K |
|||
33-HO015015-10K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,20K |
|||
33-HO015015-20K | Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA |
|||
E64C01201 | EnoGene | 20ug | EUR 458.4 |
SAA |
|||
cyt-942 | ProSpec Tany | 10µg | EUR 60 |
Description: Recombinant Human Serum Amyloid A (APO-SAA) |
Cat SAA |
|||
9004 | Life Diagnostics | 0.1 mg | EUR 500 |
Dog SAA |
|||
9005 | Life Diagnostics | 0.1 mg | EUR 500 |
Cow SAA |
|||
9007 | Life Diagnostics | 0.1 mg | EUR 500 |
Horse SAA |
|||
9003 | Life Diagnostics | 0.1 mg | EUR 500 |
Human SAA |
|||
9006 | Life Diagnostics | 0.1 mg | Ask for price |
Bovine(SAA) |
|||
QY-E60061 | Qayee Biotechnology | 96T | EUR 511.2 |
SAA Protein |
|||
abx060299-100ug | Abbexa | 100 ug | EUR 994.8 |
SAA antibody |
|||
10-7959 | Fitzgerald | 500 ug | EUR 418.8 |
Description: Mouse monoclonal SAA antibody |
SAA antibody |
|||
10-7960 | Fitzgerald | 500 ug | EUR 418.8 |
Description: Mouse monoclonal SAA antibody |
SAA antibody |
|||
10R-10351 | Fitzgerald | 100 ug | EUR 522 |
Description: Mouse monoclonal SAA antibody |
SAA antibody |
|||
20-1715 | Fitzgerald | 1 ml | EUR 165.6 |
Description: Goat polyclonal SAA antibody |
SAA antibody |
|||
20-1723 | Fitzgerald | 1 liter | Ask for price |
Description: Goat polyclonal SAA antibody |
saa Antibody |
|||
E551109-11-PU | EnoGene | 100ug | EUR 295 |
Description: Available in various conjugation types. |
SAA Antibody |
|||
GWB-50F610 | GenWay Biotech | 0.25 mg | Ask for price |
SAA Antibody |
|||
GWB-7201D0 | GenWay Biotech | 0.25 mg | Ask for price |
SAA Antibody |
|||
GWB-93451C | GenWay Biotech | 0.25 mg | Ask for price |
SAA Antibody |
|||
GWB-C04C4F | GenWay Biotech | 0.25 mg | Ask for price |
SAA Antibody |
|||
GWB-A7D37D | GenWay Biotech | 0.25 mg | Ask for price |
Human SAA/LDL Complex (SAA/LDL) Elisa Kit |
|||
EK713224 | AFG Bioscience LLC | 96 Wells | EUR 0.33 |
Human SAA/LDL Complex(SAA/LDL Complex)ELISA Kit |
|||
YLA0855HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
Human SAA/LDL Complex(SAA/LDL Complex)ELISA Kit |
|||
YLA0855HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
Mouse SAA ELISA |
|||
KT-346 | Kamiya Biomedical Company | 1 kit | EUR 467 |
Horse SAA ELISA |
|||
KT-660 | Kamiya Biomedical Company | 96 tests | EUR 573 |
Apo SAA antibody |
|||
20R-1792 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal Apo SAA antibody |
Rabbit SAA ELISA |
|||
KT-57110 | Kamiya Biomedical Company | 96 tests | EUR 998 |
Chicken SAA ELISA |
|||
KT-686 | Kamiya Biomedical Company | 96 tests | EUR 551 |
SAA-5-VV-OMe |
|||
T34481-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: SAA-5-VV-OMe |
SAA-5-VV-OMe |
|||
T34481-1g | TargetMol Chemicals | 1g | Ask for price |
Description: SAA-5-VV-OMe |
SAA-5-VV-OMe |
|||
T34481-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: SAA-5-VV-OMe |
SAA-5-VV-OMe |
|||
T34481-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: SAA-5-VV-OMe |
SAA-5-VV-OMe |
|||
T34481-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: SAA-5-VV-OMe |
Recombinant Human SAA |
|||
P0209 | FN Test | 100ug | EUR 626.83 |
Description: Recombinant Human protein for SAA |
SAA, Feline, Recombinant |
|||
30-2023 | Fitzgerald | 100 ug | EUR 388 |
Description: Feline Serum Amyloid A, Recombinant |
Cat SAA ELISA Kit |
|||
E-20SAA | Immunology Consultants Laboratory | 1 x 96 well plate | EUR 553.2 |
Rat SAA ELISA Kit |
|||
ERS0235 | Abclonal | 96Tests | EUR 625.2 |
human SAA,His tag |
|||
E4A10E03 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
Cow SAA ELISA kit |
|||
SAA-11 | Life Diagnostics | 1x 96 wells plate | EUR 500 |
Dog SAA ELISA kit |
|||
SAA-4 | Life Diagnostics | 1x 96 wells plate | EUR 475 |
Cat SAA ELISA kit |
|||
SAA-8 | Life Diagnostics | 1x 96 wells plate | EUR 475 |
Pig SAA ELISA kit |
|||
SAA-9 | Life Diagnostics | 1x 96 wells plate | EUR 475 |
Goat SAA ELISA Kit |
|||
EGTS0235 | Abclonal | 96Tests | EUR 625.2 |
Goat SAA ELISA kit |
|||
SAA-13 | Life Diagnostics | 1x 96 wells plate | EUR 500 |
Human SAA ELISA Kit |
|||
DEIA450 | Creative Diagnostics | 96T | EUR 1272 |
Description: ThisHuman SAA ELISA Kit is to be used for the in vitro quantitative determinationof human serum amyloid A (SAA) concentrations in serum, plasma, cell culture supernatant, and other biological fluids. |
Mouse SAA ELISA Kit |
|||
EMS0235 | Abclonal | 96Tests | EUR 625.2 |
Sheep SAA ELISA Kit |
|||
ESS0235 | Abclonal | 96Tests | EUR 625.2 |
SAA ELISA KIT|Human |
|||
EF000259 | Lifescience Market | 96 Tests | EUR 826.8 |
Human SAA ELISA Kit |
|||
EHS0235 | Abclonal | 96Tests | EUR 625.2 |
Mouse SAA ELISA Kit |
|||
E28L0772 | EnoGene | 96T | EUR 666.67 |
human SAA ELISA Kit |
|||
E42EH-107 | EnoGene | 96T/48T | Ask for price |
Mouse SAA ELISA KIT |
|||
E42EM-063 | EnoGene | 96T/48T | Ask for price |
Mouse SAA ELISA kit |
|||
SAA-1 | Life Diagnostics | 1x 96 wells plate | EUR 425 |
Horse SAA ELISA kit |
|||
SAA-14 | Life Diagnostics | 1x 96 wells plate | EUR 475 |
Camel SAA ELISA kit |
|||
SAA-16 | Life Diagnostics | 1x 96 wells plate | EUR 500 |
Human SAA ELISA kit |
|||
SAA-20 | Life Diagnostics | 1x 96 wells plate | EUR 475 |
Mouse SAA ELISA Kit |
|||
GWB-DB6944 | GenWay Biotech | 96 well | Ask for price |
Rabbit SAA ELISA Kit |
|||
ERTS0235 | Abclonal | 96Tests | EUR 625.2 |
Monkey SAA ELISA Kit |
|||
EMKS0235 | Abclonal | 96Tests | EUR 625.2 |
Bovine SAA ELISA Kit |
|||
EBS0235 | Abclonal | 96Tests | EUR 625.2 |
Canine SAA ELISA Kit |
|||
ECS0235 | Abclonal | 96Tests | EUR 625.2 |
Serum Amyloid A (SAA) |
|||
E35K1936 | EnoGene | 100ug | EUR 295 |
Serum Amyloid A (SAA) |
|||
E8RT1556 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
Salmon SAA ELISA kit |
|||
SAA-19 | Life Diagnostics | 1x 96 wells plate | EUR 500 |
Monkey SAA ELISA kit |
|||
SAA-3 | Life Diagnostics | 1x 96 wells plate | EUR 500 |
Porcine SAA ELISA Kit |
|||
EPS0235 | Abclonal | 96Tests | EUR 625.2 |
Chicken SAA ELISA Kit |
|||
ECKS0235 | Abclonal | 96Tests | EUR 625.2 |
Dolphin SAA ELISA kit |
|||
SAA-18 | Life Diagnostics | 1x 96 wells plate | EUR 500 |
Chicken SAA ELISA kit |
|||
SAA-5 | Life Diagnostics | 1x 96 wells plate | EUR 475 |
Anserini SAA ELISA Kit |
|||
EAS0235 | Abclonal | 96Tests | EUR 625.2 |
ELISA kit for Mouse SAA/SAA1 |
|||
EK5520 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse SAA/SAA1 in samples from serum, plasma, tissue homogenates and other biological fluids. |
ELISA kit for Human SAA/SAA1 |
|||
EK5733 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human SAA/SAA1 in samples from serum, plasma, tissue homogenates and other biological fluids. |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC942868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF594 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC942868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF594 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC802868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC802868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC702868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF770 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC702868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF770 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC882868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF488A conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC882868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF488A conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC812868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC812868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC402868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF640R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC402868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF640R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC052868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405M conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC052868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405M conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC042868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405S conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC042868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405S conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCAP2868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCAP2868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCA2868-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), APC conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCP2868-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), PerCP conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCR2868-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), RPE conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCH2868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCH2868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCB2868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Biotin conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNCB2868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Biotin conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNUB2868-100 | Biotium | 100uL | EUR 316.8 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Concentration: 0.2mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNUB2868-50 | Biotium | 50uL | EUR 486 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), 1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNUB2868-500 | Biotium | 500uL | EUR 615.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Concentration: 0.2mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC472868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF647 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC472868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF647 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC552868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF555 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC552868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF555 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC612868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF660R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC612868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF660R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC432868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF543 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC432868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF543 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC682868-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF568 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|||
BNC682868-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF568 conjugate, Concentration: 0.1mg/mL |
Human SAA/SAA1 PicoKine ELISA Kit |
|||
EK1544 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human SAA in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Cow SAA SPARCL™ Assay |
|||
SAA-SP-11 | Life Diagnostics | 1 kit | EUR 500 |
Dog SAA SPARCL™ Assay |
|||
SAA-SP-4 | Life Diagnostics | 1 kit | EUR 500 |
Cat SAA SPARCL™ Assay |
|||
SAA-SP-8 | Life Diagnostics | 1 kit | EUR 500 |
To oversee consistent application of scientific standards and methodological rigor for data acquisition, processing, and analytics, we developed standard operating procedures that reflect the logistical needs of multi-site research, and the need for well-articulated, transparent processes that can be implemented in future clinical trials.
This report details the methodology of the ABC-CT related to acquisition and QC in our Feasibility and Main Study phases. Based on our acquisition metrics from a preplanned interim analysis, we report high levels of acquisition success utilizing VT, EEG, and ET experiments in a relatively large sample of children with ASD and typical development (TD), with data acquired across multiple sites and use of a manualized training and acquisition protocol.